Skip to main content

The challenge of type 2 diabetes in children

What are the challenges of type 2 diabetes in children and adolescents? We examine the roles that dietetics, surgery and medication can play in improving outcomes.

eLearning module

Supporting weight loss in children: Getting it right

Drawing on the clinical experience of a pediatric dietitian, this easy-access guide helps HCPs troubleshoot the challenges they may face when supporting a child with type 2 diabetes to lose weight, providing practical advice and tips to achieve successful results.

Views from the clinic

Pediatric specialists highlight key points of detecting and treating type 2 diabetes in children.

When to screen for type 2 diabetes in children

AG Unnikrishnan highlights the problem of underdiagnosis of type 2 diabetes in children, and explains who to prioritize for screening (2:14).

Why type 2 diabetes is so challenging to manage in children

Phil Zeitler discusses the pathophysiology of type 2 diabetes in children, and why it is so resistant to conventional management (2:58). 

Treatment priorities in children with type 2 diabetes

Julian Hamilton-Shield explains why weight loss is the key to type 2 diabetes management in children (2:04).

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

In focus


Ethnicity and childhood type 2 diabetes: Causes and consequences

Why and how does ethnicity influence risk and management approach for pediatric type 2 diabetes? We talk to childhood obesity specialist Julian Hamilton-Shield.

At a glance

Medications for pediatric type 2 diabetes: What’s approved, what’s coming up?

We round up the medications currently approved for treating type 2 diabetes in children and adolescents and look at what agents are coming through clinical trials.


Metabolic surgery for children: Finding the sweet spot

Torsten Olbers puts the case for metabolic surgery as a treatment option for children with type 2 diabetes.

Latest news

03-02-2023 | Empagliflozin | News

DINAMO: Empagliflozin shows promise for young people with type 2 diabetes

Empagliflozin, but not linagliptin, provides “clinically relevant” improvements in glycemic control versus placebo in children and adolescents with type 2 diabetes, report the DINAMO investigators.

19-12-2022 | Early onset | News

Global type 2 diabetes burden increasing in adolescents and young adults

The incidence and burden of type 2 diabetes in young people aged 15–39 years are increasing worldwide, show data from the Global Burden of Disease Study.

22-11-2022 | Dulaglutide | News

FDA clears dulaglutide for adolescents

Click through to read more on this announcement